Dawn E. Dolan, PharmD, and Shilpa Gupta, MD

All articles by Dawn E. Dolan, PharmD, and Shilpa Gupta, MD

Cancer Control

General Oncology

PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy

By

Dawn E. Dolan, PharmD, and Shilpa Gupta, MD

September 19, 2014

[Cancer Control] Immunotherapeutic approaches to treating cancer have been evaluated during the last few decades with limited success.

Next post in General Oncology

Second List of ‘Choosing Wisely’ Oncology Guidelines Released